Čájehuvvojit 1 - 12 oktiibuot 12 bohtosis ohcui Zhan Hong Tang (22676538)', ohcanáigi: 0,01s
Aiddostahte ozu
-
1
Signal strength of ADE at the drug level ranked by reports. Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
2
Outcomes distribution of drug patients with the top 50 positive signal frequency by 4 methods (ROR PRR IC MGPS). Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
3
Time-to-onset analysis using the Weibull distribution test. Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
4
-
5
Top 50 drugs sorted by frequency of positive signals stratified by reporter – by 4 methods (ROR PRR IC MGPS). Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
6
Gender Difference analysis of the top 50 drugs ranked by frequency by four methods (ROR PRR IC MGPS). Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
7
Top 50 Drugs with positive signals by frequency – by four methods (ROR PRR IC MGPS). Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
8
Two-by-two contingency table for disproportionality analysis. Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
9
The top 50 drugs by frequency of positive signals stratified by sex – by 4 methods (ROR PRR IC MGPS). Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
10
-
11
The top 25 drugs sorted by frequency of positive signals stratified by age – by 4 methods (ROR PRR IC MGPS). Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: -
12
The principles of disproportionate measurement and the criteria for signal detection. Dahkki Jun Hua Lai (22676523)
Almmustuhtton 2025Eará dahkkit: